INTRODUCTION {#s1}
============

Among the sequelae of stroke, gait disorder has a major impact on daily life. Therefore, improving the ability to walk is one of the main purposes of rehabilitation[@r1]^)^. The characteristics of walking in hemiplegic stroke patients include reduced walking speed, decreased stride length, and asymmetric movement of the lower limbs[@r2], [@r3]^)^. The walking speed of hemiplegic stroke patients is related to activities of daily living, and those who walk faster live more actively than those who walk more slowly[@r4]^)^. Therefore, gait training is important for improving the walking speed of these patients.

In recent years, many robotic technologies have been introduced to the field of rehabilitation. In the Japanese Guidelines for the Management of Stroke 2015, rehabilitation using robotics is recommended for patients with stroke-induced hemiplegia who cannot walk well. One of the wearable walking support robots in the rehabilitation field is the Honda Walking Assist Device (HWAD) developed by Honda Research & Development, Japan. The HWAD has the Stride Management Assist (SMA^®^) system that facilitates and measures hip joint movement while walking. The HWAD is light weight and easy to wear. Previous studies of the effects of robotic-assisted gait training (RAGT) with the SMA^®^ system reported immediate improvement of walking efficiency in healthy people[@r5]^)^, and improvement of walking speed in the elderly, after long-term use[@r6]^)^. In addition, it was reported that walking speed was improved in stroke patients who received RAGT with the SMA^®^ compared to conventional gait training[@r7], [@r8]^)^. Furthermore, Arisue et al. reported that a greater improvement in the stride and walking speed was observed in the slower walking group of convalescent stroke patients compared to the faster walking group[@r9]^)^. These results suggest that the effects of RAGT with the SMA^®^ may be beneficial in stroke patients.

In biomechanical studies, Lelas et al. reported that the positive power peak values for the hip and ankle joints in the pre-swing and early swing phases were strongly correlated with increased walking speed in healthy individuals[@r10]^)^. In hemiplegic patients, Olney et al. reported that the decrease in walking speed was correlated with the plantar flexors of the ankle, hip flexors, and hip extensors of the affected lower leg[@r11], [@r12]^)^. The HWAD, however, only assists the hip joint. Therefore, it is possible that foot and ankle function may influence the improvement in walking speed observed with the HWAD. In addition, the HWAD measurement function that determines the effect and adjusts the assistance is used to evaluate hip joint movement. However, there have been no reports on the reliability of the measurement function itself. Therefore, the purpose of this study was to evaluate the reliability of the walking measurements of the HWAD and investigate the relationship between foot and ankle function as well as the HWAD-mediated improvement in walking in hemiplegic stroke patients.

PARTICIPANTS AND METHODS {#s2}
========================

Ten healthy young participants (4 males, 6 females, average age ± standard deviation (SD): 27.8 ± 3.2 years) were recruited to investigate the reliability of the walking measurement of the HWAD (Honda Motor Co., Ltd., Tokyo, Japan) ([Fig. 1](#fig_001){ref-type="fig"}Fig.1.(a) The Honda Walking Assist Device and tablet. (b) How to attach the Honda Walking Assist Device.). Two examiners (Examiner A: HWAD usage history was 5 months; Examiner B: HWAD usage history was 1 month) measured an easy 10-meter walking test (10MWT) in random order. Examiner A measured twice and Examiner B measured once. The HWAD was removed and reattached between measurements. Additionally, the initial setting of HWAD was performed in a standing position between measurements. Intra-rater reliability (Examiner A-A) and inter-rater reliability (Examiner A-B) were determined as follows: the intraclass correlation coefficient (ICC) 1,1 (one-way random single measures) and ICC 2,1 (two-way random single measures), standard error of the measurement (SEM), and the minimal detectable change (MDC) were calculated for walking speed, stride length, cadence, hip flexion angle, extension angle, and scissor angle (flexion angle + contralateral extension angle). The SEM and MDC were calculated as follows[@r13],[@r14],[@r15],[@r16],[@r17]^)^:

The MDC indicates the smallest amount of detectable change in two repeated measurements that is not due to measurement error[@r18]^)^.

Sixteen hemiplegic stroke patients (11 males, 5 females) were recruited to investigate the relationship between foot and ankle function and the immediate effects of the HWAD. The patients had the following characteristics: average age 54.2 ± 10.2 years, height 164.9 ± 8.0 cm, and body weight 64.7 ± 7.8 kg; 10 patients had hemiplegia on the right side and 6 on the left side; Brunnstrom recovery stages for the lower extremities were as follows: stage III: 2 patients, stage IV: 5 patients, stage V: 4 patients, and stage VI: 5 patients; nine of the patients were using ankle foot orthosis (AFO) and seven did not. We measured the maximum 10MWT, toe-grip strength (TGS), the cross test, and the one maximum step (OMS) width. The 10MWT was measured 3 times. We measured the first time without the HWAD (N1), the second time with the HWAD (A1), and the third time without the HWAD (N2). An assisted-walking exercise was performed for 3 minutes prior to the A1 test. The torque for the HWAD can be adjusted within a range of 0.0 (minimum)--4.0 N·m. The assisting torque was adjusted to 4.0 N·m for flexion and extension. We compared the walking speed, stride length, and hip joint angle (flexion, extension, scissors angle: flexion + contralateral extension angle) to the three 10MWT trials using repeated measures analysis of variance. Using these data, the participants were divided into two groups according to the median rate of change in velocity that was determined by calculating the ratio of A1/N1 (high change group: HCG ≥1.033, low change group: LCG \<1.033). The TGS, cross test, OMS width, and walking parameters were compared using unpaired t-tests between the two groups. The presence or absence of orthosis was compared between the two groups using the Pearson's χ^2^ test. IBM^®^ SPSS Statistics for Windows, version 23 (IBM Corp., Armonk, NY, USA) was used for all statistical analyses, and the significance level was set at p\<0.05.

The study protocol adhered to the guidelines of the Declaration of Helsinki and was approved by the Tokyo Research Safety Ethics Committee of the Tokyo Metropolitan University (Approval No.16022) and Tokyo Metropolitan Rehabilitation Hospital (Approval No. 14, 2016), Tokyo, Japan. In addition, the study participants were fully informed of the content and purpose of the research, and the study procedures were carried out after obtaining written consent from the participants.

RESULTS {#s3}
=======

The results for the reliability of the walking measurements of the HWAD are shown in [Table 1](#tbl_001){ref-type="table"}Table 1.Reliability of the walking measurement for the HWAD in healthy participantsAverage (SD)ICC 1,1 (95% CI)ICC 2,1 (95% CI)SD (d)SEMMDC95Walking speed (m/min)69.9 (13.3)0.962 (0.822 to 0.993)0.975 (0.874 to 0.996)3.920.7642.12Step length (cm)62.6 (9.8)0.986 (0.932 to 0.998)0.980 (0.895 to 0.997)1.700.2010.56Cadence (step/min)111.0 (6.5)0.901 (0.579 to 0.982)0.912 (0.566 to 0.984)3.000.9442.62Flexion angle (°)33.0 (4.4)0.758 (0.414 to 0.914)0.799 (0.494 to 0.930)2.831.3923.86Extension angle (°)6.5 (4.5)0.789 (0.476 to 0.926)0.706 (0.315 to 0.894)2.661.2223.39Scissor angle (°)39.9 (3.4)0.893 (0.710 to 0.964)0.881 (0.677 to 0.960)1.680.5501.52ICC: intraclass correlation coefficient; 95%CI: 95% confidence interval; SD: standard deviation; SEM: standard error of measurement; MDC: minimal detectable change; MDC95: 95%CI of MDC; Scissor angle: includes flexion + contralateral extension angle.. In the comfortable 10MWT, three participants who had a change in walking time of 0.5 seconds or more were excluded due to changes in walking speeds. Therefore, data from 7 participants (14 lower limbs) were included in the determination of reliability.

The results of the relationship between foot and ankle function and the HWAD-facilitated improvement in gait function

are shown in [Tables 2](#tbl_002){ref-type="table"} and[3](#tbl_003){ref-type="table"}Table 2.Comparison of the three 10-meter walking tests conducted in hemiplegic stroke patients (n=16)N1A1N2Walking speed (m/min)69.1 ± 18.170.8 ± 17.572.3 ± 19.5Step length (cm)60.4 ± 9.161.1 ± 8.660.5 ± 10.3Cadence (steps/min)113.4 ± 16.5114.6 ± 15.7117.8 ± 16.0Flexion angle -- paralyzed side (°)29.3 ± 6.636.5 ± 6.529.3 ± 7.4\*1\*2Flexion angle -- non-paralyzed side (°)35.0 ± 6.145.0 ± 6.936.4 ± 5.9\*1\*2Extension angle -- paralyzed side (°)8.9 ± 4.312.7 ± 4.311.3 ± 4.8\*1\*3Extension angle -- non-paralyzed side (°)11.9 ± 5.711.0 ± 8.712.9 ± 6.4Scissor angle -- paralyzed side (°)32.2 ± 6.940.4 ± 11.335.4 ± 8.0\*1\*2Scissor angle -- non-paralyzed side (°)39.4 ± 5.655.8 ± 8.244.9 ± 6.5\*1\*2\*3Scissor angle: includes flexion angle + contralateral extension angle.\*p\<0.05.N1: without assist; A1: with assist; N2: without assist; \*1: Significant differences between N1 and A1; \*2: significant differences between A1 and N2; \*3: significant differences between N1 and N2.. For the three 10MWTs, the flexion and scissor angles on both the paralyzed and non-paralyzed sides and the extension angle on the paralyzed side were greater in A1 than in N1 and N2 tests (p\<0.05, [Table 2](#tbl_002){ref-type="table"}). There were no significant differences in the other gait parameters tested between the three 10MWTs. The comparison of the HCG and LCG groups showed that the HCG group had a significantly smaller OMS value on both the paralyzed and non-paralyzed sides compared to the LCG group (p\<0.05, [Table 3](#tbl_003){ref-type="table"}Table 3.Comparison between the HCG and LCGHCG (n=8)LCG (n=8)Walking speed (m/min)61.6 ± 14.076.6 ± 19.4Step length (cm)56.8 ± 4.864.0 ± 11.1Cadence (steps/min)108.3 ± 18.6118.5 ± 13.4Flexion angle - paralyzed side (°)27.7 ± 7.031.0 ± 6.2Flexion angle - non-paralyzed side (°)34.1 ± 6.536.0 ± 6.0Extension angle - paralyzed side (°)8.9 ± 4.09.0 ± 4.9Extension angle - non-paralyzed side (°)12.2 ± 7.011.6 ± 4.5Scissors angle - paralyzed side (°)42.5 ± 8.239.8 ± 12.7Scissors angle - non-paralyzed side (°)45.0 ± 7.743.0 ± 6.6Cross testA-P (cm)11.8 ± 2.012.6 ± 1.7L-R (cm)15.2 ± 2.618.8 ± 10.0Rectangular area (cm^2^)185.4 ± 59.8244.0 ± 141.3OMS (/leg length)Paralyzed side0.46 ± 0.120.70 ± 0.19\*Non-paralyzed side0.39 ± 0.160.78 ± 0.18\*TGS (/weight)Paralyzed side0.06 ± 0.050.15 ± 0.05\*Non-paralyzed side0.16 ± 0.050.17 ± 0.08Number of patients using AFO (paralyzed side)72\*\*p\<0.05.A-P: anterior-posterior; L-R: left-right; OMS: one maximum step; TGS: toe grip strength;HCG: high change group (walking speed A1/N1 ≥1.033); LCG: low change group (walking speed A1/N1 \<1.033).). The HCG group also had a smaller TGS value on the paralyzed side and significantly more participants using an orthosis compared to the LCG group (p\<0.05). There were no significant differences in the cross test and walking parameters between the HCG and LCG groups.

DISCUSSION {#s4}
==========

In this study, we evaluated the reliability of the measurement function for the HWAD in healthy young participants. In addition, we investigated the relationship between foot and ankle function and the walking improvement facilitated by the HWAD in hemiplegic stroke patients. Our findings revealed that both the intra-rater ICC (1,1) and inter-rater ICC (2,1) values for all the parameters tested were greater than 0.70. The HWAD changed the hip movement significantly, but did not change the maximum walking speed in the hemiplegic patients. The group of stroke participants with a greater change in velocity when using the HWAD (HCG) had smaller OMS on both sides and smaller TGS on the paralyzed side, and many of them used orthoses compared to the LCG participants.

According to the criteria of Kuwabara et al., an ICC of \>0.9 indicated great, \>0.80 indicated good, 0.70--0.79 indicated normal, and \<0.60 indicated poor reliability[@r17]^)^. According to the criteria of Landis and Koch, an ICC of 0.81--1.00 indicated almost perfect, 0.61--0.80 indicated substantial, and 0.41--0.60 indicated normal reliability[@r19]^)^. In our study, using the criteria described above, the ICCs of hip flexion and extension angle (0.706--0.799) can be classified as normal to substantial reliability, and the scissor angle ICCs (0.881--0.893) can be classified as good to almost perfect reliability. Therefore, we demonstrated that the HWAD measurement function for walking parameters was reliable. In this study, the reliability of the scissor angle measurements was higher than the reliability of the flexion and extension angle measurements. A possible explanation for this result could be attributed to the influence of the displacement of the baseline (0 degrees) of flexion-extension during detachment-attachment, and the small initial setting, as the scissor angle was the sum of the flexion angle and the contralateral extension angle. The reliability of the HWAD makes it a useful evaluation tool for measuring the walking parameters.

The results of our study support the concept that the HWAD, and possibly other robotic assistance devices, may not immediately offer a benefit for highly functional patients and the benefit may be dependent on the level of paralysis. Furthermore, it is possible that an immediate improvement of the walking speed was not observed because the HWAD assisted only the hip joint and not the ankle joint. Patients with more severe paralysis would have lower TGS and a greater need for orthoses. In order to increase the OMS on the paralyzed side, it is necessary for the patient to increase the swing of the paralyzed side. To increase the OMS on the non-paralyzed side, the lower limbs on the paralyzed side must be stabilized in the posture and the swing on the non-paralyzed side must be increased. Thus, paralysis would affect the bilateral OMS. The immediate effects of the HWAD in stroke patients may also be influenced by the use of AFO.

This study was limited in that the relationship was unclear between the hip and other lower limb joints (such as the knee and ankle), which is important for hemiplegic walking, because HWAD can only measure the hip joint. Therefore, future research would need to use 3-dimensional motion analysis during walking with HWAD. We recruited only healthy young participants in our reliability study and we did not examine the reliability of hemiplegic patients. A study of reliability in hemiplegic patients who can walk, with or without a walking aid, reported high reliability in walking speed and joint movement[@r20]^)^. Therefore, examinations of hemiplegic patients wearing HWAD would be equally reliable. However, it is necessary to examine the reliability of HWAD in hemiplegic patients.

In conclusion, this study demonstrated for the first time that the HWAD measurements were reliable and may be useful as an evaluation tool in hemiplegic stroke patients, as well as other groups of patients with gait disorders. Furthermore, our study shows that the HWAD does not immediately affect walking speed and further research will be necessary to determine the long-term walking improvements afforded by this device. We propose that when using the HWAD, consideration should be given to the level of paralysis and the presence of orthoses to determine the efficacy of this device in hemiplegic stroke patients.
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